Loading…
Kura Oncology, Inc. is projected to rise to $14.22 by 2027, a +39% move from its current price of $10.24. KURA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.88 | $10.24 | $10.61 | -0.04% |
| May 30 | $9.73 | $10.23 | $10.77 | -0.07% |
| May 31 | $9.61 | $10.23 | $10.89 | -0.11% |
| Jun 1 | $9.52 | $10.23 | $10.99 | -0.14% |
| Jun 2 | $9.43 | $10.22 | $11.08 | -0.18% |
| Jun 3 | $9.36 | $10.22 | $11.16 | -0.22% |
| Jun 4 | $9.29 | $10.21 | $11.23 | -0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.29 | $10.21 | $11.23 | -0.25% |
| Week 2 | $8.91 | $10.19 | $11.65 | -0.50% |
| Week 3 | $8.62 | $10.16 | $11.98 | -0.75% |
| Week 4 | $8.38 | $10.14 | $12.26 | -1.00% |
| Week 5 | $8.18 | $10.11 | $12.51 | -1.25% |
| Week 6 | $7.99 | $10.09 | $12.73 | -1.50% |
| Week 7 | $7.82 | $10.06 | $12.94 | -1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer. Its portfolio includes KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors.
The company is headquartered in San Diego, California.
Kura Oncology trades at $10.41 and has a market capitalization of $924.14M, with a rank of 2598. The near-term technical picture sits in a bullish posture within a 30-day range of $8.16 to $13.28, supported by a $8.75 level and resisted at $11.25. The stock’s current price sits inside this range, as volatility remains elevated at about 70% annually.
The long-range outlook shows upside potential across the years, with the 2026 average forecast at $10.41 and a trajectory toward higher prices by 2050, including a 2050 maximum of $203.44 and a 2050 average of $97.20.
A major floor 27.7% below — a decisive break under it would weaken the trend.
The nearest floor, 14.6% below — buyers have tended to step in here.
The nearest ceiling, 9.9% above — a clean break opens room to run.
A major ceiling 22.9% above — clearing it would confirm fresh momentum.
Key KURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.67 | Sell | $10.39 | Sell |
| MA 10 | $10.00 | Buy | $10.14 | Buy |
| MA 20 | $9.62 | Buy | $9.80 | Buy |
| MA 50 | $9.08 | Buy | $9.35 | Buy |
| MA 100 | $8.88 | Buy | $9.18 | Buy |
| MA 200 | $9.21 | Buy | $9.16 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.95 | Neutral |
| Stoch RSI (14) | 43.33 | Neutral |
| CCI (20) | 75.90 | Neutral |
| Williams %R (14) | -44.10 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 8.70 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 55.90 | Neutral |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 1.24 | Buy |
| Ultimate (7,14,28) | 61.23 | Neutral |
| Momentum (10) | 0.56 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 11.11 | Sell |
| ADX (14) | 17.36 | Neutral |
| ATR (14) | 0.33 | Info |
The sentiment is bullish, with RSI(14) at 60. The stock trades above the 50-day and near the 200-day simple moving averages, which are $9.05 and $9.19 respectively. Near-term support sits at $8.75 and resistance at $11.25, framing a constructive setup for the coming weeks.
The 30-day range spans from $8.16 to $13.28, highlighting meaningful upside and downside potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.40 | $10.24 | $15.50 | 0% | Neutral | |
| $10.93 | $14.22 | $19.78 | +39% | Bullish | |
| $12.60 | $17.01 | $24.75 | +66% | Bullish | |
| $13.32 | $18.54 | $27.95 | +81% | Bullish | |
| $12.99 | $18.60 | $28.88 | +82% | Bullish | |
| $14.01 | $20.59 | $32.80 | +101% | Bullish | |
| $13.82 | $20.80 | $33.92 | +103% | Bullish | |
| $14.62 | $22.52 | $37.49 | +120% | Bullish | |
| $18.75 | $29.52 | $50.08 | +188% | Bullish | |
| $20.96 | $33.71 | $58.23 | +229% | Bullish | |
| $22.33 | $39.60 | $73.64 | +287% | Bullish | |
| $46.33 | $98.01 | $202.70 | +857% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.40 | $10.24 | $12.09 | +0.00% |
| June 2026 | $8.50 | $10.05 | $12.21 | -1.89% |
| July 2026 | $8.29 | $9.91 | $12.26 | -1.36% |
| August 2026 | $8.64 | $10.42 | $13.06 | +5.14% |
| September 2026 | $8.78 | $10.67 | $13.52 | +2.38% |
| October 2026 | $8.62 | $10.55 | $13.50 | -1.12% |
| November 2026 | $8.97 | $11.04 | $14.25 | +4.67% |
| December 2026 | $9.62 | $11.91 | $15.50 | +7.86% |
Click any year to see its month-by-month KURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, KURA is projected to trade between $7.40 and $15.50, averaging $10.24 — a potential gain of 0% from today's $10.24. Price action looks broadly range-bound.
Kura Oncology, Inc.'s 2027 outlook centres on $14.22, within a $10.93 to $19.78 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, KURA could reach as high as $24.75, with a base case around $17.01 and support toward $12.60 — roughly +66% from $10.24. Momentum favours further upside here.
Expect KURA to range from $13.32 to $27.95 through 2029. The $18.54 average target implies a +81% move from current prices. That is up +9% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The KURA price prediction for 2030 points to an average of $18.60 (low $12.99, high $28.88) — a potential gain of +82% on today's $10.24. Momentum favours further upside here.
In 2031, KURA is projected to trade between $14.01 and $32.80, averaging $20.59 — a potential gain of +101% from today's $10.24. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Kura Oncology, Inc.'s 2032 outlook centres on $20.80, within a $13.82 to $33.92 range. That is up +1% on the projected 2031 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2033, KURA could reach as high as $37.49, with a base case around $22.52 and support toward $14.62 — roughly +120% from $10.24. Buyers look set to stay in control over this stretch.
Expect KURA to range from $18.75 to $50.08 through 2034. The $29.52 average target implies a +188% move from current prices. That is up +31% on the projected 2033 average. Momentum favours further upside here.
The KURA price prediction for 2035 points to an average of $33.71 (low $20.96, high $58.23) — a potential gain of +229% on today's $10.24. Buyers look set to stay in control over this stretch.
In 2040, KURA is projected to trade between $22.33 and $73.64, averaging $39.60 — a potential gain of +287% from today's $10.24. That is up +17% on the projected 2035 average. Momentum favours further upside here.
Kura Oncology, Inc.'s 2050 outlook centres on $98.01, within a $46.33 to $202.70 range. That is up +148% on the projected 2040 average. That marks a +857% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in KURA today (≈ 97.65625 KURA) could be worth
$9,571.33
+$8,571.33 (+857%) by 2050 · US Dollar
Based on the average projected KURA price of $98.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KURAwould be worth at today's price.
$1,000 invested in KURA on May 27, 2025 (≈ 178.253115 KURA) would be worth
$1,825.31
+$825.31 (+82.5%) today · 1.83× · US Dollar
Based on a KURA entry price of $5.61 vs. today's $10.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.34 | $990.33 | -1.0% |
| 1 month ago | $9.07 | $1,129 | +12.9% |
| 3 months ago | $8.65 | $1,183.82 | +18.4% |
| 6 months ago | $12.14 | $843.49 | -15.7% |
| 1 year ago | $5.61 | $1,825.31 | +82.5% |
| All time (5.0y) ago | $22.35 | $458.17 | -54.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KURA forecast.
Our base-case forecast reaches $20.00 around 2031.
Implied market cap at $20.00: $1.78B
The multi-year forecast shows sustained upside, with 2027 at an average of $14.40 and bullish sentiment, advancing to 2028 at $17.25 and 2029 at $18.77. By 2030 the average is projected at $18.71 with a 79.7% ROI and bullish sentiment, followed by continued strength into 2031 ($20.70, 98.9%), 2032 ($20.79, 99.7%), and 2033 ($22.38, 115%). The growth accelerates through 2034 ($29.53, 183.7%), 2035 ($33.73, 224%), then toward 2040 ($39.15, 276.1%) and eventually 2050 ($97.20, 833.7%) with a bullish stance throughout.
These figures illustrate a long-run path of progressive upside, though they are estimates and not guarantees.
Tap a question to reveal the answer.
2030 forecast shows an average price of $18.71 with a max of $29.25, a min of $12.97, and a 79.7% ROI; sentiment is bullish.
The forecast displays bullish sentiment from 2027 onward, with rising averages and ROIs up to 833.7% by 2050; 2026 is shown as neutral.
Yes. The forecast max grows to $58.79 by 2035 and to $73.55 by 2040, with a long-run max of $203.44 by 2050, indicating $50 is within projected upside.
The current price is $10.41.
The 2050 forecast shows an average of $97.20 with a max of $203.44 and a min of $44.88, with a 833.7% ROI and bullish sentiment.
Kura Oncology, Inc. Community Discussion
0Share your Kura Oncology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.